Recent Opportunities

NIDDK
The goal of the NIDDK-sponsored Diabetic Complications Consortium (DiaComp) is to provide an environment that will foster communication and collaboration between investigator communities involved in complications research. The DiaComp-PTP will provide investigators with access to pilot funds to pursue additional preclinical studies of promising new therapeutics.
Funding Opportunities sorted by recent Post Date
Title FOA Post Expire Purpose
NIH
The Role of Sleep Deficiency in Persons with Type 1 Diabetes: Sleep, Glycemic Control, and Cardiovascular Risk (R01 Clinical Trial Optional) RFA-HL-24-008 2023-07-20 2023-10-12 The purpose of this Notice of Funding Opportunity (NOFO) is to elucidate the contribution of sleep deficiency and circadian disruption to metabolic and cardiovascular pathobiology, disease trajectory, and treatment response in individuals living with Type 1 Diabetes (T1D).
NIH
The Role of Sleep Deficiency in Persons with Type 1 Diabetes: Sleep, Glycemic Control, and Cardiovascular Risk (R34 Clinical Trial Optional) RFA-HL-24-009 2023-07-20 2023-10-12 This Notice of Funding Opportunity (NOFO) will support preliminary studies aimed at obtaining information necessary to guide the design of a full randomized control trial to test whether sleep and circadian targeted interventions improve the clinical course and treatment outcomes in individuals with Type 1 Diabetes (T1D).
NIDDK
NIDDK Catalyst Award (DP1 Clinical Trial Not Allowed) RFA-DK-23-014 2023-06-15 2023-09-29 The NIDDK Catalyst Award is designed to complement NIDDK's traditional, investigator-initiated grant programs by supporting individual scientists who propose pioneering and transformational studies in topic areas of interest to NIDDK's Division of Diabetes, Endocrinology and Metabolic Diseases, and to NIDDK's Division of Digestive Diseases and Nutrition.
NIDDK
Integration of Novel Measures for Improved Classification of Type 2 Diabetes (U01, Clinical Trials Not Allowed) RFA-DK-23-019 2023-05-31 2023-10-27 The purpose of this NOFO is to create a consortium to bring together investigative teams for integration of multiple data types, including markers of organ or tissue function, into analysis approaches for stratifying individuals with type 2 diabetes (T2D) and developing more precise definitions of disease.
NIDDK
Integration of Novel Measures for Improved Classification of Type 2 Diabetes – Biostatistics Research Center (U01 Clinical Trial Not Allowed) RFA-DK-23-020 2023-05-31 2023-10-27 This NOFO invites applications for a Biostatistics Research Center to participate in a consortium aimed at improving understanding of heterogeneity of type 2 diabetes (T2D).
NIH
Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed) RFA-TR-23-011 2023-04-20 2023-05-23 NCATS is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS.